Two Sigma Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
+52,779
| New | +$1.52M | ﹤0.01% | 1964 |
|
|
2024
Q4 | – | Sell |
-5,414
| Closed | -$277K | – | 3184 |
|
|
2024
Q3 | $277K | Sell |
5,414
-5,386
| -50% | -$275K | ﹤0.01% | 2637 |
|
|
2024
Q2 | $484K | Sell |
10,800
-108,080
| -91% | -$4.84M | ﹤0.01% | 2316 |
|
|
2024
Q1 | $5.56M | Sell |
118,880
-74,221
| -38% | -$3.47M | 0.01% | 870 |
|
|
2023
Q4 | $6.87M | Sell |
193,101
-208,852
| -52% | -$7.43M | 0.02% | 782 |
|
|
2023
Q3 | $12M | Buy |
401,953
+310,418
| +339% | +$9.23M | 0.03% | 511 |
|
|
2023
Q2 | $1.65M | Buy |
91,535
+59,335
| +184% | +$1.07M | ﹤0.01% | 1522 |
|
|
2023
Q1 | $517K | Buy |
32,200
+7,588
| +31% | +$122K | ﹤0.01% | 2112 |
|
|
2022
Q4 | $450K | Buy |
24,612
+1,356
| +6% | +$24.8K | ﹤0.01% | 2008 |
|
|
2022
Q3 | $457K | Sell |
23,256
-23,489
| -50% | -$462K | ﹤0.01% | 1772 |
|
|
2022
Q2 | $872K | Sell |
46,745
-74,032
| -61% | -$1.38M | ﹤0.01% | 1549 |
|
|
2022
Q1 | $2.65M | Sell |
120,777
-16,515
| -12% | -$362K | 0.01% | 1178 |
|
|
2021
Q4 | $3.9M | Sell |
137,292
-9,000
| -6% | -$256K | 0.01% | 1001 |
|
|
2021
Q3 | $3.08M | Buy |
146,292
+29,982
| +26% | +$631K | 0.01% | 1137 |
|
|
2021
Q2 | $2.19M | Buy |
116,310
+58,366
| +101% | +$1.1M | 0.01% | 1274 |
|
|
2021
Q1 | $885K | Buy |
57,944
+4,033
| +7% | +$61.6K | ﹤0.01% | 1650 |
|
|
2020
Q4 | $761K | Buy |
53,911
+26,834
| +99% | +$379K | ﹤0.01% | 1445 |
|
|
2020
Q3 | $424K | Sell |
27,077
-26,735
| -50% | -$419K | ﹤0.01% | 1474 |
|
|
2020
Q2 | $943K | Buy |
+53,812
| New | +$943K | ﹤0.01% | 1181 |
|